Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwCAR-T 2023

The 5th International Workshop on CAR-T
14–16 April 2023 | Scottsdale, AZ

iwCAR-T 2023

The 5th International Workshop on CAR-T
14–16 April 2023 | Scottsdale, AZ

Explore presentations by leading experts from iwCAR-T 2023 below.

Emerging CARs and future challenges Genitourinary cancers Lung cancer Logistics & manufacturing Gastrointestinal cancers Head/neck and CNS cancers Melanoma & sarcomas

Session 1: Emerging CARs and future challenges in solid tumors

Mathew Angelos
HER2-targeted CAR-macrophages for solid tumors
Mathew Angelos University of Pennsylvania
Sebastian Kobold
Migratory engineering of T cells for cancer therapy
Sebastian Kobold Ludwig Maximilian University of Munich

Session 2: Genitourinary cancers

Vivek Narayan
Next steps in safety and efficacy for CAR-T
Vivek Narayan University of Pennsylvania, Philadelphia, PA
Nicholas Zorko
NK cells for GU malignancies
Nicholas Zorko University of Minnesota
David Hong
Autologous T-cells engineered with TCRs
David Hong The University of Texas MD Anderson Cancer Center

Session 3: CAR-T clinical advances in lung cancer

Adam Schoenfeld
Updates on TIL therapy in lung cancer
Adam Schoenfeld Memorial Sloan Kettering Cancer Center
William Go
The challenges and the future of cell therapy
William Go A2 Biotherapeutics, Agoura Hills, CA

Session 4: Logistics & manufacturing

Julian Molina
CAR T-cell studies in solid tumors - logistic issues
Julian Molina Mayo Clinic, Rochester, MN
Sarah Nikiforow
Manufacturing/FACT and ASTCT 80/20
Sarah Nikiforow Dana-Farber Cancer Institute

Session 5: Gastrointestinal cancers

Joel Randolph Hecht
GI malignancies; I-O to cell therapy
Joel Randolph Hecht UCLA Health, Los Angeles
Diane Simeone
scSeq in pancreatic cancer
Diane Simeone NYU Langone Health, New York City, NY
Benjamin Schlechter
TAC01-HER2 cell therapy in HER2+ solid tumors
Benjamin Schlechter Dana-Farber Cancer Institute
Zhaohui Jin
2-specific chimeric antigen receptor T-cell therapy
Zhaohui Jin Mayo Clinic

Session 6: Head/neck and CNS cancers

Jong Chul Park
Development of novel therapeutics for H&N cancer
Jong Chul Park Massachusetts General Hospital
Kedar Kirtane
Cellular immunotherapy in head and neck cancers
Kedar Kirtane H. Lee Moffitt Cancer Center & Research Institute
Rizwan Romee
Engineering NK cells for enhanced solid tumor targeting
Rizwan Romee Dana-Farber Cancer Institute

Session 7: Melanoma & sarcomas

Sebastian Klobuch
Tumor-infiltrating lymphocyte therapy
Sebastian Klobuch The Netherlands Cancer Institute
John Mullinax
Intraoperative principles related to TIL procurement
John Mullinax H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

The continued success of the iwCAR-T meeting is in no small part due to the ongoing funding of supporters, allowing a unique opportunity for clinicians to be brought together to facilitate interactive and stimulating debates to help improve patient outcomes.
For more information about supporting future meetings and activities, please contact us here.

iwCAR-T 2023 was supported by:

The content of VJOncology is intended for healthcare professionals